Physicians' Academy for Cardiovascular Education
Slides: The benefits of icosapent ethyl  in addressing residual risk: What is the evidence?

Slides: The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

Slides (presentation) - Apr. 17, 2023 - Lale Tokgözoğlu, MD - Ankara Turkey

Find here the slides of the presentation by Lale Tokgözoğlu, titled "The benefits of icosapent ethyl in addressing residual risk: What is the evidence?".

Download the slides

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: